Novartis Institutes for BioMedical Research, Inc.

10% owner at NTLA

Sold, on record
$27.9M
Dollars the filings state
Form 4 sales
1
Latest Dec 12, 2017
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • NTLAIntellia Therapeutics, Inc.10% owner

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale NTLAUnusual
    Dec 12, 2017 2017

    Sold 1.5M shares at $18.30 ($27.9M)

    Novartis Institutes for BioMedical Research, Inc., 10% owner

    Sold 26.9% of holdings ($103M position)4.1M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (1)

Form 144 notices and Form 4 sales by Novartis Institutes for BioMedical Research, Inc.
Source
Dec 12, 2017Dec 14, 2017NTLA10% ownerForm 4 sale1.5M$27.9M26.9%UnusualSEC